RCM

RA Capital Management Portfolio holdings

AUM $9.76B
1-Year Est. Return 103.63%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+103.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.11B
AUM Growth
+$235M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
31
New
Increased
Reduced
Closed

Top Buys

1
+$46.4M
2
+$19M
3
+$14.7M
4
INSM icon
Insmed
INSM
+$13.8M
5
CMTA
Clementia Pharmaceuticals Inc.
CMTA
+$9.57M

Top Sells

1
+$33.9M
2
+$22.5M
3
+$19.6M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$13.7M
5
AKBA icon
Akebia Therapeutics
AKBA
+$12M

Sector Composition

1 Healthcare 95.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$2.67M 0.24%
33,437
27
– –
-836,337
28
– –
-731,531
29
– –
-69,804
30
– –
-497,157
1
2